Skip to content

Pfizer PFE Current Debt

Current Debt at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.03B-78.2%
Eli Lilly logo
Eli LillyLLY
$4B-0.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$11.69B+1.4%
Amgen logo
AmgenAMGN
$5.44B+61.4%
Incyte logo
IncyteINCY
$4.26M-4.8%
AbbVie logo
AbbVieABBV
$0-100%

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$143.91B+4.2%
Enterprise value$206.58B+4.2%
P/E11.9×
P/S2.3×+0.1×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's current debt?
Pfizer (PFE) reported current debt of $3.86B in Q1 2026.
How has Pfizer's current debt changed year-over-year?
Pfizer's current debt increased by 3.0% year-over-year, from $3.75B to $3.86B.
What is the long-term trend for Pfizer's current debt?
Over 5 years (2020 to 2025), Pfizer's current debt has grown at a 8.4% compound annual growth rate (CAGR), from $2B to $3B.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.